Practitioner Review: Treatments for Tourette syndrome in children and young people - a systematic review.
Craig WhittingtonMary PennantTim KendallCristine GlazebrookPenny TraynerMadeleine GroomTammy HedderlyIsobel HeymanGeorgina JacksonStephen JacksonTara MurphyHugh RickardsMary RobertsonJeremy SternChris HollisPublished in: Journal of child psychology and psychiatry, and allied disciplines (2016)
When medication is considered appropriate for the treatment of tics, the balance of clinical benefits to harm favours α2-adrenergic receptor agonists (clonidine and guanfacine) as first-line agents. Antipsychotics are likely to be useful but carry the risk of harm and so should be reserved for when α2-adrenergic receptor agonists are either ineffective or poorly tolerated. There is evidence that HRT/CBIT is effective, but there is no evidence for HRT/CBIT alone relative to combining medication and HRT/CBIT. There is currently no evidence to suggest that the physical and dietary interventions reviewed are sufficiently effective and safe to be considered as treatments.